Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40963

EIF2AK3 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

EIF2AK3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting PERK, the ER stress sensor kinase, in HEK293T human embryonic kidney cells. This model disrupts the PERK-eIF2??-ATF4 signaling axis, eliminating stress-induced eIF2?? phosphorylation and downstream induction of ATF4 and CHOP. The cells enable dissection of unfolded protein response pathways, ER stress biology, and apoptosis regulation. Applications include PERK inhibitor screening, Wolcott-Rallison syndrome modeling, and investigation of ER stress in cancer and neurodegeneration using assays such as phospho-eIF2?? Western blotting, RT-qPCR of ATF4/CHOP, and cell viability analyses.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    EIF2AK3

    Gene Identifier

    NCBI Gene ID 9451

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EIF2AK3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting EIF2AK3 in HEK293T cells. This heterogeneous pool of loss-of-function cells avoids clonal artifacts, providing a robust model without single-cell cloning. The polyclonal format captures diverse gene-disruption events, enabling population-based functional studies.

HEK293T cells are immortalized human embryonic kidney epithelia transformed with sheared adenovirus type 5 DNA and expressing SV40 large T antigen. These features ensure high transfectability and robust protein production, making them a mainstay for transient/stable expression, lentiviral generation, and pathway analysis. Their epithelial origin and vigorous growth suit them for studying stress-responsive signaling and gene regulation.

EIF2AK3 encodes PERK, an ER-resident kinase acting as a primary sensor of the unfolded protein response. ER stress triggers BiP/GRP78 dissociation, PERK oligomerization, and autophosphorylation. Active PERK phosphorylates eIF2??, transiently attenuating global translation while selectively upregulating ATF4 translation. ATF4 induces stress-responsive genes including CHOP, GADD34, and NRF2-dependent antioxidants. This PERK-eIF2??-ATF4 signaling branch integrates with the integrated stress response, governing cell fate decisions between adaptation and apoptosis.

In HEK293T cells, EIF2AK3 knockout removes the principal ER stress-sensing kinase, enabling dissection of PERK-dependent and -independent UPR arms. Researchers can examine how loss of eIF2?? phosphorylation influences translational regulation, ATF4/CHOP induction, and apoptosis upon stressors like tunicamycin or thapsigargin. This model is valuable for exploring PERK roles in cancer drug resistance, metabolic adaptation, and ER stress-linked neurodegeneration. The polyclonal population minimizes clonal bias and captures diverse knockout phenotypes, enhancing reproducibility.

Applications include PERK-eIF2??-ATF4 pathway analysis, PERK inhibitor screening, modeling of Wolcott-Rallison syndrome ER stress, and studies of ER stress in cancer and neurodegeneration. Common assays involve Western blotting for phospho-eIF2?? and PERK, RT-qPCR for ATF4/CHOP/GADD34, apoptosis assays with caspase or annexin V, and cell viability tests. For more information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)